MODIFICATION
A -- PREVENT Cancer Preclinical Drug Development Program: Preclinical Efficacy and Intermediate Endpoint Biomarkers - Amendment 1
- Notice Date
- 8/16/2017
- Notice Type
- Modification/Amendment
- NAICS
- 541711
— Research and Development in Biotechnology
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Office of Acquisitions-Treatment and Support Branch, Bldg 244, Room 112, Frederick, Maryland, 21702
- ZIP Code
- 21702
- Solicitation Number
- N01CN55003
- Archive Date
- 9/15/2017
- Point of Contact
- Nicole Belanger, Phone: 301-624-8754, Kelly Dempsey, Phone: 301-624-8788
- E-Mail Address
-
belangern@mail.nih.gov, kelly.dempsey@nih.gov
(belangern@mail.nih.gov, kelly.dempsey@nih.gov)
- Small Business Set-Aside
- N/A
- Description
- PREVENT Efficacy Statement of Work This amendment adds the Statement of Work and extends the due date.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/FCRF2/N01CN55003/listing.html)
- Record
- SN04631383-W 20170818/170816232022-5c2e0d0248733553b839361df072df16 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |